-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against James River Group Holdings, Ltd. (JRVR)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR). The investigation concerns whether James River and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

James River owns and operates a group of specialty insurance and reinsurance companies. The Company includes excess and surplus lines, specialty admitted insurance, and casualty reinsurance segments.

On November 8, 2023, James River disclosed that the Company identified an error in its accounting for reinstatement premium on a specialty casualty reinsurance treaty in its Excess & Surplus Lines segment from the Company’s previous financial statement. As a result, the Company previously overstated its net written and earned premiums of $9.4 million and $12.3 million, respectively, for the second quarter of 2023. Additionally, the Company previously overstated its net income of $7.8 million and $10.4 million for the second quarter of 2023, due to its accounting error. On this news, the price of James River shares declined by $0.99 per share, or approximately 7%, from $14.14 per share to close at $13.15 on November 8, 2023

If you purchased or otherwise acquired James River securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: https://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:JRVR

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

FWRD SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Forward Air Corporation (“Forward Air” or the “Company”) (NASDAQ:FWRD) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 7, 2026, Forward Air reported its first quarter 2026 financial results and provided a cus...

CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Certara, Inc. (“Certara” or the “Company”) (NASDAQ:CERT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 11, 2026, Certara reported its first quarter 2026 financial results. Certara disclosed that services re...

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. A...
Back to Newsroom